Timing of an announcement, page-106

I'm cautiously optimistic here. Have horrific memories of FTT last year, when they appointed a corporate adviser to assist them with M&A activities post the release of their phase 2 results. This indicated that they were bullishly anticipating positive results. The results were subsequently released and the placebo was more effective than the actual treatment. As a result the share price dropped 97% on open.

The reason I mention this is that with biotechs, the outcome is binary. Quite simply, it's either the treatment is effective or it is not. There is a risk here and I hope that BOT didnt just make yesterday's announcement in the same manner as FTT above.

The indicators that the treatment is successful have been much more prominent for BOT though in the last 6 months, which makes me a bit more confident that the results are successful. In any event, we'll watch and wait the outcome, hopefully tomorrow!